RELAPSED ADVANCED LYMPHOMAS
Clinical trials for RELAPSED ADVANCED LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADVANCED LYMPHOMAS trials appear
Sign up with your email to follow new studies for RELAPSED ADVANCED LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame advanced lymphomas in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will take the pill, and researchers will m…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New pill aims to fight advanced lymphoma when other treatments fail
Disease control Recruiting nowThis early-stage trial tests an oral drug called AUR112 in 40 adults with relapsed advanced lymphoma. The main goals are to check safety, find the right dose, and see how the drug moves through the body. It is the first time this drug is being tested in humans.
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC